Humana reported a Q3 2026 adjusted loss of $0.70 per share, driven by increased intangible asset amortization and investment valuation adjustments, and raised its full-year 2026 Adjusted EPS guidance to at least $9.50.
Humana reported a Q3 2026 adjusted loss of $0.70 per share, driven by increased intangible asset amortization and investment valuation adjustments, and raised its full-year 2026 Adjusted EPS guidance to at least $9.50.